Amarin Corp Plc (AMRN)

[Pharmacydude]

momoney
This is not about playing the next move perfectly. This is about the current SP being $1.85 in 2022 with amazing R-IT results, EU approval and a great reimbursement rate in the UK. I never would have imagined Amarin at $1.85 at this point in time given my belief that V is a life saving, practice changing completely new therapy that should be flying off the shelves. But it’s not. It’s not “selling itself” like one former board poster predicted. What does this mean? It means I was wrong. Very wrong. And if I am to develop an accurate view of Amarin’s future I need to start listening to people who don’t see the future through the rose coloured glasses I have been wearing. WS has a completely different view of Amarin’s future and I want to understand that view to adjust my expectations and adjust my investment strategy.
My opinions/views/expectations are completely clouded by the positive scientific data. I need to appreciate the financial perspective and to do that I need to listen to people with different opinions/views/expectations. Someone with the balls to short this incredibly undervalued asset obviously has a different perspective than I do, so I want to hear it.